LifeMD Reports Third Quarter 2024 Results
Portfolio Pulse from
LifeMD reported strong Q3 2024 results with a 38% increase in total revenues to $53.4 million, driven by a 65% rise in telehealth revenue. The company achieved a record gross margin of 90.6% and a 33% increase in adjusted EBITDA to $3.7 million. LifeMD also reported positive cash flow from operations.
November 07, 2024 | 9:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LifeMD reported a strong Q3 2024 with significant revenue growth and improved profitability metrics. The company's telehealth segment showed robust performance, contributing to a record gross margin and positive cash flow.
LifeMD's strong financial performance, including significant revenue growth and improved margins, is likely to positively impact its stock price. The telehealth segment's growth and positive cash flow are particularly noteworthy.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100